RSA Viewpoints

A Report from BIO-Europe Spring 2017

The blue skies and balmy weather of Barcelona were the perfect backdrop for BIO-Europe Spring this year. The 2,400 biotech pros at the conference...

Report from J.P. Morgan 2017

So, that’s the J.P. Morgan Healthcare Conference done for another year. For just a few highly energised days it felt as if nearly every...

Shaping up for growth in a world of change

The 34th FT Global Pharmaceutical and Biotechnology Conference brought together life science and pharma companies as well as emerging new players. Discussions centered on industry challenges,...

Change for the better

Talent is more global now than ever. In light of the recent Brexit vote and the fact that demand for talent in Europe is...

What next for EU and UK biotech boards?

In light of the UK’s decision to leave the EU, it’s worth revisiting our recent Talent Equity® report on what makes successful biotech boards. The question...